Impact of TH and DCX mRNAs detection in high-risk neuroblastoma patients' outcome

被引：0
|
作者：
Canete, A. [1 ]
Yanez, Y. [1 ]
Grau, E. [1 ]
Palanca, S. [2 ]
Perez, G. [2 ]
Antuna, M. J. [3 ]
Marquez, C. [4 ]
Gallego, S. [5 ]
Urberuaga, A. [6 ]
Castel, V. [1 ]
机构：
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
[2] Hosp Univ & Politecn La Fe, Mol Biol Lab, Valencia, Spain
[3] Hosp Univ Cent Asturias, Asturias, Spain
[4] Hosp Univ Virgen del Rocio, Seville, Spain
[5] Hosp Univ Vall dHebron, Barcelona, Spain
[6] Hosp Univ Cruces, Vizcaya, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1624
引用
收藏
页码：S356 / S357
页数：2
相关论文
共 50 条
  • [1] TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients
    Yanez, Yania
    Hervas, David
    Grau, Elena
    Oltra, Silvestre
    Perez, Gema
    Palanca, Sarai
    Bermudez, Mar
    Marquez, Catalina
    Canete, Adela
    Castel, Victoria
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (03) : 573 - 580
  • [2] TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients
    Yania Yáñez
    David Hervás
    Elena Grau
    Silvestre Oltra
    Gema Pérez
    Sarai Palanca
    Mar Bermúdez
    Catalina Márquez
    Adela Cañete
    Victoria Castel
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 573 - 580
  • [3] Impact of radiation therapy on outcome in high-risk neuroblastoma
    Bouzid, N.
    Couanet, D. Valteau
    Bolle, S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S883 - S883
  • [4] Outcome in patients with refractory high-risk neuroblastoma.
    Siddiqui, Amir Bari
    Oppong, Akosua
    Yuan, Cindy
    Gao, Guimin
    Bagatell, Rochelle
    Berg, Katherine
    Sokol, Elizabeth
    MacQuarrie, Kyle
    Pinto, Navin R.
    Gollapudi, Anurekha
    Mody, Rajen
    Wolfe, Ian
    Shusterman, Suzanne
    Foster, Jennifer
    Smith, Valeria
    Cohn, Susan Lerner
    Desai, Ami Vijay
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Outcome of children with high-risk neuroblastoma
    Fluchel, M
    Hawkins, DS
    Felgenhauer, J
    Douglas, JJ
    Sanders, JE
    Park, JR
    PEDIATRIC RESEARCH, 2003, 53 (04) : 300A - 301A
  • [6] An Impact of Etoposide Treatment on Survival for High-Risk Neuroblastoma Patients
    Kiyotani, C.
    Shioda, Y.
    Terashima, K.
    Osumi, T.
    Kato, M.
    Tomizawa, D.
    Kanamori, Y.
    Fuchimoto, Y.
    Nakazawa, A.
    Yoshioka, T.
    Fuji, H.
    Miyazaki, O.
    Matsumoto, K.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S198 - S198
  • [7] Distinct Expression Profiles of Neuroblastoma-Associated mRNAs in Peripheral Blood and Bone Marrow of Non-High-Risk and High-Risk Neuroblastoma Patients
    Nakatani, Naoko
    Win, Kaung Htet Nay
    Mon, Cho Yee
    Fujikawa, Tomoko
    Uemura, Suguru
    Saito, Atsuro
    Ishida, Toshiaki
    Mori, Takeshi
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    Inoue, Shotaro
    Nishimura, Akihiro
    Nino, Nanako
    Tamura, Akihiro
    Yamamoto, Nobuyuki
    Nozu, Kandai
    Nishimura, Noriyuki
    BIOLOGY-BASEL, 2024, 13 (05):
  • [8] Radiological Description and Impact on Outcome of Postoperative Residue After High-Risk Neuroblastoma Surgery
    Irtan, S.
    Le Pointe, H. Ducou
    Fayard, C.
    Gabra, H.
    Granata, C.
    Avanzini, S.
    Pio, L.
    Gomez-Chacon, J.
    Braungart, S.
    Stenman, J.
    Sundquist, F.
    Stromgren, J.
    Plantaz, D.
    Matthyssens, L.
    Jauquier, N.
    Bjornland, K.
    Ingegerd, A.
    Cross, K.
    McHugh, K.
    Sarnacki, S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S37 - S38
  • [9] TUMOR HISTOLOGY FOLLOWING INDUCTION CHEMOTHERAPY AND/OR HIGH-DOSE CHEMOTHERAPY AND ITS IMPACT ON THE OUTCOME OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA
    Hishiki, T.
    Horie, H.
    Higashimoto, Y.
    Yotsumoto, K.
    Komatsu, S.
    Okimoto, Y.
    Kakuda, H.
    Taneyamai, Y.
    Yoshida, H.
    Iwai, J.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S331 - S331
  • [10] PATTERNS OF RELAPSE IN HIGH-RISK NEUROBLASTOMA PATIENTS
    Li, R.
    Sridharan, M.
    London, W.
    Lee, S.
    Shusterman, S.
    Marcus, K.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S208 - S208
12345